INJECTION SITE CELLULITIS

This adverse event was reported 1860 times

These drugs are most commonly taken by patients reporting INJECTION SITE CELLULITIS:

# Drug Count
0 INTERFERON BETA-1A 270
1 ETANERCEPT 141
2 NALTREXONE 109
3 INTERFERON BETA-1B 108
4 BUPRENORPHINE 89
5 ADALIMUMAB 68
6 TREPROSTINIL 55
7 GABAPENTIN 54
8 OMEPRAZOLE MAGNESIUM 48
9 GLATIRAMER ACETATE 46
See all common drugs associated with INJECTION SITE CELLULITIS

INJECTION SITE CELLULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TECHNETIUM TC 99M OXIDRONATE 5 0.0368
1 LENACAPAVIR SODIUM 17 0.0336
2 MOTIXAFORTIDE 2 0.0196
3 METHENAMINE MANDELATE 2 0.0107
4 DEGARELIX 37 0.0069
5 ALUMINUM HYDROXIDE GEL 1 0.0068
6 INTERFERON BETA-1B 108 0.0057
7 ANTIFUNGAL LIQUID SPRAY 1 0.0053
8 PENICILLIN G BENZATHINE 6 0.0044
9 RILONACEPT 5 0.0043
See all drugs enriched for association with INJECTION SITE CELLULITIS